Merck & Co., Inc. (NYSE:MRK)‘s stock had its “neutral” rating reaffirmed by Zacks in a report issued on Tuesday, Stock Ratings News reports. They currently have a $52.00 price target on the stock. Merck & Co., Inc. (NYSE:MRK) stock opened at $49.74 in last trading session, and closed at $50.05, trading in the range of $49.53 – $50.08. The stock showed a positive weekly performance of 1.40%.
China’s drug watchdog halted imports of a medication from drug giant Pfizer Inc. (NYSE:PFE) citing a late application for the drug—the latest incident marking increased Chinese scrutiny of the pharmaceutical industry. Pfizer Inc. (NYSE:PFE) shares closed at $30.63 on last trade day, by losing -0.20%. Stock 52 week range is $25.33 – $32.50. Company’s market capitalization is $198.52 billion.
After data indicated that the market share of Johnson & Johnson (NYSE:JNJ)’s prostate cancer drug, Zytiga, rose slightly in November versus September and October, Wells Fargo expects Zytiga’s strong overall growth to continue into 2014, driven by increasing penetration in the pre-chemo market segment and OUS uptake. The firm keeps an Outperform rating on the stock. Johnson & Johnson (NYSE:JNJ) stock fell -0.77% and finished the last session at $91.59. The EPS of the stock remained 4.48. Company’s market capitalization is $258.42 billion.
Inovio Pharmaceuticals Inc (NYSEMKT:INO) currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened at $2.87 in last trading session and closed at $2.90. The 52 week range of the stock is $0.49 – $3.03 and the day range was $2.82 – $2.91.
Leave a Reply